Clinical trials
Phase 3 Myeloproliferative Disorders trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AOP Orphan Pharmaceuticals AG | 3 |
| Celgene | 2 |
| Incyte Corporation | 2 |
| Ariad Pharmaceuticals | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Geron Corporation | 1 |
| Novartis Pharmaceuticals | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 12 |
| Primary Myelofibrosis | 6 |
| Hematologic Diseases | 5 |
| Bone Marrow Diseases | 4 |
| Polycythemia | 3 |
| Polycythemia Vera | 3 |
| Anemia | 2 |
| Leukemia | 2 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.